DOCSLIB.ORG

9, 2015 Glasgow, Scotland, United Kingdom Abstracts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Volume 23 Supplement 1 June 2015 www.nature.com/ejhg European Human Genetics Conference 2015 June 6 - 9, 2015 Glasgow, Scotland, United Kingdom Abstracts EJHG_OFC.indd 1 4/1/2006 10:58:05 AM ABSTRACTS European Human Genetics Conference joint with the British Society of Genetics Medicine June 6 - 9, 2015 Glasgow, Scotland, United Kingdom Abstracts ESHG 2015 | GLASGOW, SCOTLAND, UK | WWW.ESHG.ORG 1 ABSTRACTS Committees – Board - Organisation European Society of Human Genetics ESHG Office Executive Board 2014-2015 Scientific Programme Committee European Society President Chair of Human Genetics Helena Kääriäinen, FI Brunhilde Wirth, DE Andrea Robinson Vice-President Members Karin Knob Han Brunner, NL Tara Clancy, UK c/o Vienna Medical Academy Martina Cornel, NL Alser Strasse 4 President-Elect Yanick Crow, FR 1090 Vienna Feliciano Ramos, ES Paul de Bakker, NL Austria Secretary-General Helene Dollfus, FR T: 0043 1 405 13 83 20 or 35 Gunnar Houge, NO David FitzPatrick, UK F: 0043 1 407 82 74 Maurizio Genuardi, IT E: [email protected] Deputy-Secretary-General Daniel Grinberg, ES www.eshg.org Karin Writzl, SI Gunnar Houge, NO Treasurer Erik Iwarsson, SE Andrew Read, UK Xavier Jeunemaitre, FR Mark Longmuir, UK Executive Officer Jose C. Machado, PT Jerome del Picchia, AT Dominic McMullan, UK Giovanni Neri, IT William Newman, UK Minna Nyström, FI Pia Ostergaard, UK Francesc Palau, ES Anita Rauch, CH Samuli Ripatti, FI Peter N. Robinson, DE Kristel van Steen, BE Joris Veltman, NL Joris Vermeesch, BE Emma Woodward, UK Karin Writzl, SI Board Members Liaison Members Yasemin Alanay, TR Stan Lyonnet, FR Martina Cornel, NL Martijn Breuning, NL Julie McGaughran, AU Ulf Kristoffersson, SE Pascal Borry, BE Bela Melegh, HU Thomas Liehr, DE Nina Canki-Klain, HR Will Newman, UK Milan Macek Jr., CZ Ana Carrió, ES Markus Nöthen, DE Tayfun Ozcelik, TR Isabella Ceccherini, IT Markus Perola, FI Milena Paneque, PT Angus John Clarke, UK Dijana Plaseska-Karanfilska, MK Hans Scheffer, NL Koen Devriendt, BE Trine E. Prescott, NO Heather Skirton, UK Munis Dundar, TR Inga Prokopenko, UK GertJan B. van Ommen, NL Francesca Forzano, IT Hans Scheffer, NL Brunhilde Wirth, DE Peter Kroisel, AT Jörg Schmidtke, DE Dorit Lev, IL Heather Skirton, UK Further information on structure and organisation can be found on the website www.eshg.org Future European Human Genetics Conferences European Human Genetics Conference 2016 European Human Genetics Conference 2018 Barcelona, Spain Milan, Italy May 21 – 24, 2016 June 16 – 19, 2018 1967 – 2017: 50th Anniversary of the ESHG The European Human Genetics Conference 2017 Copenhagen, Denmark May 27 – 30, 2017 2 ESHG 2015 | GLASGOW, SCOTLAND, UK | WWW.ESHG.ORG ABSTRACTS TABLE OF CONTENTS Spoken Presentations 4 Plenary Lectures................................................................................................................PL1.1 – PL5.1 ..................... 4 Concurrent Symposia ........................................................................................................S01.1 – S16.3 ..................... 6 Educational Sessions ........................................................................................................ES1.1 – ES9.2 .................... 14 Concurrent Sessions .........................................................................................................C01.1 – C23.6 .................... 17 Posters 52 P01. Reproductive Genetics/Prenatal Genetics ..................................................................P01.01-91 ........................ 52 P02. Sensory Disorders (Eye, Ear, Pain) ............................................................................P02.01-62 ........................ 72 P03. Internal Organs & Endocrinology (Lung, Kidney, Liver, Gastrointestinal) ...................P03.01-41 ........................ 85 P04. Skeletal, Connective Tissue, Ectodermal and Skin Disorders ....................................P04.01-78 ........................ 94 P05. Cardiovascular Disorders ............................................................................................P05.01-85 .......................111 P06. Metabolic and Mitochondrial Disorders .......................................................................P06.01-70 ...................... 129 P07. Immunology and Hematopoetic System .....................................................................P07.01-25 ...................... 145 P08. Intellectual Disability ....................................................................................................P08.01-73 ...................... 151 P09. Neurogenetic and Psychiatric Disorders ...................................................................P09.001-138 .................... 166 P10. Neuromuscular Disorders ...........................................................................................P10.01-40 ...................... 196 P11. Multiple Malformation/Anomalies Syndromes ...........................................................P11.001-138 .................... 205 P12. Cancer Genetics .......................................................................................................P12.001-146 .................... 236 P13. Basic Mechanisms In Molecular and Cytogenetics .....................................................P13.01-41 ...................... 267 P14. New Diagnostic Approaches, Technical Aspects & Quality Control ..........................P14.001-110 .................... 275 P15. Personalized/Predictive Medicine and Pharmacogenomics .......................................P15.01-36 ...................... 298 P16. Omics/Bioinformatics ..................................................................................................P16.01-63 ...................... 307 P17. Epigenetics and Gene Regulation ...............................................................................P17.01-37 ...................... 320 P18. Genetic Epidemiology/Population Genetics/Statistical Methodology and Evolutionary Genetics .................................................................................................P18.01-96 ...................... 328 P19 Genetic Counselling/Education/Public Services .........................................................P19.01-59 ...................... 349 P20. Psychological/Ethical/Legal Issues .............................................................................P20.01-28 ...................... 361 Published Abstracts J01.01 - J20.02 367 Abstracts of the Sixth International Workshop on the History of Human Genetics 479 Indices 484 Keyword Index .............................................................................................................................................................484 Author Index ................................................................................................................................................................498 Click on the topics in the table of content to jump to the according page. Abstracts highlighted with are talks of Young investigator Candidates. Abstracts highlighted with are ESHG Poster Award Candidates. ESHG 2015 | GLASGOW, SCOTLAND, UK | WWW.ESHG.ORG 3 ABSTRACTS PLENARY LECTURES Back to index PLENARY LECTURES - - PL1.1 Introduction: Möbius syndrome (MBS) is a rare congenital neurological dis Chromosome conformation and long-distance gene regulation order characterized by facial and abducens nerve paralysis. Additional con N. Benabdallah1, S. Bhatia1, I. Williamson1, W. Bickmore2; genital anomalies are frequently associated. The etiology of this syndrome 1MRC Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh, United Kingdom, has been intensely debated and both teratogenic factors and genetic causes- 2Edinburgh, United Kingdom. have been suggested. However, despite numerous clinical and molecular investigations since the description of the first patients in 1880 it has re mained elusive. Long-range gene regulation first became apparent in mammalian genomes Material and Methods: We hypothesized that de novo mutations contribute- through Mendelian disease genetics associated with extreme phenotypes- to the MBS phenotype and therefore performed exome sequencing in eight in human, and developmental genetics in the mouse. It is now appreciated isolated MBS patients. All identified de novo variants were subsequently se that long-range enhancers - found as far away as 1 megabase from their tar quenced in a cohort of 103 MBS patients. The role of two candidate genes in get gene and located either in intergenic regions or in introns - are key in- MBS was addressed by morphological analysis of the knockout mouse brain.- controlling the precise spatial and temporal expression of genes. Deletion, Results: We report de novo mutations in two different genes PLXND1 and translocation or point mutations can abrogate the function of these ele REV3L. Analysis of the Plxnd1 and Rev3l-knockout mice detected neuro- ments in Rare Disease. However, the majority of human genetic variation pathological findings similar to those found in MBS. Strikingly, both mouse associated with common and complex disease and quantitative traits also models exhibited a reduced number of motoneurons in the facial motor nu maps to intergenic regions that are likely the site of enhancers. Therefore, cleus, caused by defective neural migration in the Plxnd1-mutant mice or lessons learnt from studying enhancer dysfunction in rare disease will be disrupted cellular proliferation in Rev3l-heterozygous mice. Conclusions:- important
Recommended publications
  • Federation to Hold “Conversation with Michael Oren” on Nov. 30

    Federation to Hold “Conversation with Michael Oren” on Nov. 30

    November 6-19, 2020 Published by the Jewish Federation of Greater Binghamton Volume XLIX, Number 36 BINGHAMTON, NEW YORK Federation to hold “Conversation with Michael Oren” on Nov. 30 By Reporter staff said Shelley Hubal, executive “delightful.” Liel Leibovitz, an Oren served as Israel’s ambassador to The Jewish Federation of Greater Bing- director of the Federation. “I Israeli-American journalist and the United States for almost five years hamton will hold a virtual “Conversation look forward to learning how author, wrote that “Oren delivers before becoming a member of Knesset and with Michael Oren” about his new book of he came to write the many sto- a heartfelt and heartbreaking deputy minister in the Prime Minister’s short stories, “The Night Archer and Other ries that appear in his book. I account of who we are as a spe- Office. Oren is a graduate of Princeton Stories,” on Monday, November 30, at would also like to thank Rabbi cies – flawed, fearful, and lonely and Columbia universities. He has been noon. Dora Polachek, associate professor of Barbara Goldman-Wartell for but always open-hearted, always a visiting professor at Harvard, Yale and romance languages and literatures at Bing- alerting us to this opportunity.” trusting that transcendence is Georgetown universities. In addition to hamton University, will moderate. There is Best-selling author Daniel possible, if not imminent.” (For holding four honorary doctorates, he was no cost for the event, but pre-registration Silva called “The Night Archer The Reporter’s review of the awarded the Statesman of the Year Medal is required and can be made at the Feder- and Other Stories” “an extraor- book, see page 4.) by the Washington Institute for Near East ation website, www.jfgb.org.
  • A 1.37-Mb 12P11.22-P11.21 Deletion Coincident with a 367-Kb 22Q11.2

    A 1.37-Mb 12P11.22-P11.21 Deletion Coincident with a 367-Kb 22Q11.2

    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 74e78 Contents lists available at ScienceDirect Taiwanese Journal of Obstetrics & Gynecology journal homepage: www.tjog-online.com Short Communication A 1.37-Mb 12p11.22ep11.21 deletion coincident with a 367-kb 22q11.2 duplication detected by array comparative genomic hybridization in an adolescent girl with autism and difficulty in self-care of menstruation Chih-Ping Chen a,b,c,d,e,f,*, Shuan-Pei Lin b,g,h,i, Schu-Rern Chern b, Peih-Shan Wu j, Jun-Wei Su a,k, Chen-Chi Lee a, Wayseen Wang b,l a Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan b Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan c Department of Biotechnology, Asia University, Taichung, Taiwan d School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan e Institute of Clinical and Community Health Nursing, National Yang-Ming University, Taipei, Taiwan f Department of Obstetrics and Gynecology, School of Medicine, National Yang-Ming University, Taipei, Taiwan g Department of Medicine, Mackay Medical College, New Taipei City, Taiwan h Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan i Mackay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan j Gene Biodesign Co. Ltd, Taipei, Taiwan k Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan l Department of Bioengineering, Tatung University, Taipei, Taiwan article info abstract Article history: Objective: To present an array comparative genomic hybridization (aCGH) characterization of a 12p11.22 Accepted 21 October 2013 ep11.21 microdeletion and 22q11.2 microduplication in an adolescent girl with autism, mental retar- dation, facial dysmorphism, microcephaly, behavior problems, and an apparently balanced reciprocal Keywords: translocation of t(8;12)(q24.3;p11.2).
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, Mmohamed@Health.Usf.Edu

    Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]

    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed.
  • Computational and Experimental Approaches for Evaluating the Genetic Basis of Mitochondrial Disorders

    Computational and Experimental Approaches for Evaluating the Genetic Basis of Mitochondrial Disorders

    Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Lieber, Daniel Solomon. 2013. Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders. Doctoral dissertation, Harvard University. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11158264 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders A dissertation presented by Daniel Solomon Lieber to The Committee on Higher Degrees in Systems Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Systems Biology Harvard University Cambridge, Massachusetts April 2013 © 2013 - Daniel Solomon Lieber All rights reserved. Dissertation Adviser: Professor Vamsi K. Mootha Daniel Solomon Lieber Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders Abstract Mitochondria are responsible for some of the cell’s most fundamental biological pathways and metabolic processes, including aerobic ATP production by the mitochondrial respiratory chain. In humans, mitochondrial dysfunction can lead to severe disorders of energy metabolism, which are collectively referred to as mitochondrial disorders and affect approximately 1:5,000 individuals. These disorders are clinically heterogeneous and can affect multiple organ systems, often within a single individual. Symptoms can include myopathy, exercise intolerance, hearing loss, blindness, stroke, seizures, diabetes, and GI dysmotility.
  • Dominant Optic Atrophy

    Dominant Optic Atrophy

    Lenaers et al. Orphanet Journal of Rare Diseases 2012, 7:46 http://www.ojrd.com/content/7/1/46 REVIEW Open Access Dominant optic atrophy Guy Lenaers1*, Christian Hamel1,2, Cécile Delettre1, Patrizia Amati-Bonneau3,4,5, Vincent Procaccio3,4,5, Dominique Bonneau3,4,5, Pascal Reynier3,4,5 and Dan Milea3,4,5,6 Abstract Definition of the disease: Dominant Optic Atrophy (DOA) is a neuro-ophthalmic condition characterized by a bilateral degeneration of the optic nerves, causing insidious visual loss, typically starting during the first decade of life. The disease affects primary the retinal ganglion cells (RGC) and their axons forming the optic nerve, which transfer the visual information from the photoreceptors to the lateral geniculus in the brain. Epidemiology: The prevalence of the disease varies from 1/10000 in Denmark due to a founder effect, to 1/30000 in the rest of the world. Clinical description: DOA patients usually suffer of moderate visual loss, associated with central or paracentral visual field deficits and color vision defects. The severity of the disease is highly variable, the visual acuity ranging from normal to legal blindness. The ophthalmic examination discloses on fundoscopy isolated optic disc pallor or atrophy, related to the RGC death. About 20% of DOA patients harbour extraocular multi-systemic features, including neurosensory hearing loss, or less commonly chronic progressive external ophthalmoplegia, myopathy, peripheral neuropathy, multiple sclerosis-like illness, spastic paraplegia or cataracts. Aetiology: Two genes (OPA1, OPA3) encoding inner mitochondrial membrane proteins and three loci (OPA4, OPA5, OPA8) are currently known for DOA. Additional loci and genes (OPA2, OPA6 and OPA7) are responsible for X-linked or recessive optic atrophy.
  • RRC Annual Report 2008 Layout

    RRC Annual Report 2008 Layout

    Ex panding Our Dialogue Colleagues of Other Faiths “House of Israel” in Ghana Spiritual Searchers in Northern California Also: RRC Launches Mission, Vision, Values Statement 2008 Annual Report A Message From the President By Rabbi Dan Ehrenkrantz uring the time I served as the rabbi for Bnai Keshet in Montclair, NJ, a local Baptist church closed its doors. Our synagogue had just put up a new building, and the church decided to donate some of their cash assets to us. I remember thinking at the time how astounded my ancestors would have D been. I had grown up with family stories of pogroms, with Christian symbols used to incite violence. And now, not so many years later, my synagogue was receiving a large cash gift from, of all places, a church. Yet now, for Reconstructionist Jews, that turn of events may seem fairly natural. In the movement’s foundational years, Mordecai M. Kaplan shaped the ideological basis for a changed relationship with other peoples and other religions: Judaism is not God’s chosen religion, and Jews are not the chosen people. Because we don’t have a monopoly on truth, we should seek to learn from diverse religious traditions and communities. Our special obligations toward the Jewish community should inspire us to work for the betterment of others. And so we actively seek to bring our message—a message of religious tolerance combined with religious passion—to others. We seek to be emissaries for peaceful, creative and engaged coexistence among peoples and religions. And we seek to bring cultural change to the Jewish community by sharing our unique approach to Jewish life.
  • Placenta-Derived Exosomes Continuously Increase in Maternal

    Placenta-Derived Exosomes Continuously Increase in Maternal

    Sarker et al. Journal of Translational Medicine 2014, 12:204 http://www.translational-medicine.com/content/12/1/204 RESEARCH Open Access Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy Suchismita Sarker1, Katherin Scholz-Romero1, Alejandra Perez2, Sebastian E Illanes1,2,3, Murray D Mitchell1, Gregory E Rice1,2 and Carlos Salomon1,2* Abstract Background: Human placenta releases specific nanovesicles (i.e. exosomes) into the maternal circulation during pregnancy, however, the presence of placenta-derived exosomes in maternal blood during early pregnancy remains to be established. The aim of this study was to characterise gestational age related changes in the concentration of placenta-derived exosomes during the first trimester of pregnancy (i.e. from 6 to 12 weeks) in plasma from women with normal pregnancies. Methods: A time-series experimental design was used to establish pregnancy-associated changes in maternal plasma exosome concentrations during the first trimester. A series of plasma were collected from normal healthy women (10 patients) at 6, 7, 8, 9, 10, 11 and 12 weeks of gestation (n = 70). We measured the stability of these vesicles by quantifying and observing their protein and miRNA contents after the freeze/thawing processes. Exosomes were isolated by differential and buoyant density centrifugation using a sucrose continuous gradient and characterised by their size distribution and morphology using the nanoparticles tracking analysis (NTA; Nanosight™) and electron microscopy (EM), respectively. The total number of exosomes and placenta-derived exosomes were determined by quantifying the immunoreactive exosomal marker, CD63 and a placenta-specific marker (Placental Alkaline Phosphatase PLAP).
  • Literature Mining Sustains and Enhances Knowledge Discovery from Omic Studies

    Literature Mining Sustains and Enhances Knowledge Discovery from Omic Studies

    LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES by Rick Matthew Jordan B.S. Biology, University of Pittsburgh, 1996 M.S. Molecular Biology/Biotechnology, East Carolina University, 2001 M.S. Biomedical Informatics, University of Pittsburgh, 2005 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2016 UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE This dissertation was presented by Rick Matthew Jordan It was defended on December 2, 2015 and approved by Shyam Visweswaran, M.D., Ph.D., Associate Professor Rebecca Jacobson, M.D., M.S., Professor Songjian Lu, Ph.D., Assistant Professor Dissertation Advisor: Vanathi Gopalakrishnan, Ph.D., Associate Professor ii Copyright © by Rick Matthew Jordan 2016 iii LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES Rick Matthew Jordan, M.S. University of Pittsburgh, 2016 Genomic, proteomic and other experimentally generated data from studies of biological systems aiming to discover disease biomarkers are currently analyzed without sufficient supporting evidence from the literature due to complexities associated with automated processing. Extracting prior knowledge about markers associated with biological sample types and disease states from the literature is tedious, and little research has been performed to understand how to use this knowledge to inform the generation of classification models from ‘omic’ data. Using pathway analysis methods to better understand the underlying biology of complex diseases such as breast and lung cancers is state-of-the-art. However, the problem of how to combine literature- mining evidence with pathway analysis evidence is an open problem in biomedical informatics research.
  • From the Rabbi

    From the Rabbi

    WINTER NOVEMBER 2017-FEBRUARY 2018 Chai Lights CONGREGATION BETH ISRAEL • BERKELEY From the Rabbi Questions & Answers: Halakha This year during our very joyous celebrations of Simchat Torah, we had the unique P.9-10 opportunity to honor some of our shul’s most devoted life-long learners: Bella Barany, Yaakov Harari, Jory Gessow, and Preston Grant. Each has exemplified an unrelenting Preston Grant has been an independ- Laws of Chanukah attachment to Torah learning and ex- ent learner of Tanach for many years. P.11-12 hibited their resolute commitment to If you visit his home office, you will mastering areas of Torah study. quickly be struck by various charts, hanging around the room, which out- In my eleven years at CBI, I can line the literary structure of several hardly identify a single class that was chapters and books of Tanach. This not attended by Bella Barany as well is in keeping with Preston’s deep in- as by Yaakov Harari. Bella, as some volvement in CBI’s class on Psalms Gan Shalom P.04 know, learns at CBI’s Beit Midrash on that took place in our community long a daily basis, sometimes with a study ago, as well as Preston’s critical in- New Members P.06-07 partner and sometimes on her own. volvement in helping to create and launch M. Victoria Sutton’s classes on CBI Classes P.14-15 Besides attending classes at CBI, it the books of Tanach. seems like Yaakov attends any Jew- Calendar P.16-18 ish-related lecture at UC Berkeley as On the Shabbat right after Simchat well as other local Jewish institutions.
  • 1 Genome-Wide Comparisons of Variation in Linkage Disequilibrium

    1 Genome-Wide Comparisons of Variation in Linkage Disequilibrium

    Downloaded from genome.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Genome-wide comparisons of variation in linkage disequilibrium Yik Y. Teo1,*, Andrew E. Fry1, Kanishka Bhattacharya1, Kerrin S. Small1, Dominic P. Kwiatkowski1,2, Taane G. Clark1,2 1 Wellcome Trust Centre for Human Genetics, University of Oxford, United Kingdom 2 Wellcome Trust Sanger Institute, Hinxton, United Kingdom Running title: Genome-wide comparisons of LD Keywords: linkage disequilibrium, imputation, positive selection, meta-analysis, genome-wide association study * Corresponding author: Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, United Kingdom. Email: [email protected], phone: +44 1865 287712, fax: +44 1865 287 501. ABSTRACT Current genome-wide surveys of common diseases and complex traits fundamentally aim to detect indirect associations where the SNPs carrying the association signals are not biologically active but are in linkage disequilibrium (LD) with some unknown functional polymorphisms. Reproducing any novel discoveries from these genome-wide scans in independent studies is now a prerequisite for the putative findings to be accepted. Significant differences in patterns of LD between populations can affect the portability of phenotypic associations when the replication effort or meta-analyses are attempted in populations that are distinct from the original population which the genome-wide study is performed in. Here we introduce a novel method for genome-wide analyses of LD variations between populations that allow the identification of candidate regions with different patterns of LD. The evidence of LD variation provided by the introduced method correlated with the degree of differences in the frequencies of the most common haplotype across the populations.
  • Alterações De Número De Cópias Genômicas Em Hepatoblastomas: Microarranjos Genômicos E Sequenciamento De Nova Geração

    Alterações De Número De Cópias Genômicas Em Hepatoblastomas: Microarranjos Genômicos E Sequenciamento De Nova Geração

    Juliana Sobral de Barros Alterações de número de cópias genômicas em hepatoblastomas: microarranjos genômicos e sequenciamento de nova geração Chromosomal copy number changes in hepatoblastomas: genomic microarrays and next generation sequencing São Paulo 2019 Juliana Sobral de Barros Alterações de número de cópias genômicas em hepatoblastomas: microarranjos genômicos e sequenciamento de nova geração Chromosomal copy number changes in hepatoblastomas: genomic microarrays and next generation sequencing Dissertação apresentada ao Departamento de Genética e Biologia Evolutiva do Instituto de Biociências da Universidade de São Paulo, para a obtenção de Título de Mestre como requisito para obtenção do título de Mestre em Ciências, na área de concentração Biologia (Genética). Orientadora: Prof.ª Dr.ª Ana Cristina Victorino Krepischi EXEMPLAR CORRIGIDO O original encontra-se disponível no Instituto de Biociências. São Paulo 2019 FICHA CATALOGRÁFICA Barros, Juliana Sobral de Alterações de número de cópias genômicas em hepatoblastomas: microarranjos genômicos e sequenciamento de nova geração / Juliana Sobral de Barros; orientadora: Ana Cristina Victorino Krepischi. - São Paulo, 2019. 136 f. Dissertação (Mestrado) - Instituto de Biociências da Universidade de São Paulo. Departamento de Genética e Biologia evolutiva. 1. Hepatoblastoma. 2. Alteração de número de cópias. 3. Microarranjo genômico. 4. Sequenciamento de nova geração. 5. Tumor embrionário. I. Universidade de São Paulo. Instituto de Biociências. Departamento de Genética e Biologia evolutiva.